Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells — Stella

Home/Ovary Neoplasm/

View on ClinicalTrials.gov

Recruiting

Back to Ovary Neoplasm trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina

Key details

Phase

Early testing

Sponsor

UNC Lineberger Comprehensive Cancer Center

Enrollment target

~27 participants

Started

July 2024

Primary completion

April 2036

Age range

18 Years and older

Sex

Female only

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

Last updated April 2026